PRECISION BIOSCIENCES INC — Director's Dealing 2023

Oct 27, 2023

SEC Form 4/A — Form 4/A

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2023-08-18

Reporting Person: Kelly John Alexander (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-18	Common Stock	P	90000	$0.48	Acquired	383340	Direct

Footnotes

F1: This amendment is being filed to correct the Transaction Code (as set forth in Box 3). The Form 4, as originally filed, inadvertently reported the Transaction Code as "A."

F2: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.47 to $0.485. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.